Table 3.
Group/treatment | TER [Ω × cm2] | Isc [μA/cm2] | ||
---|---|---|---|---|
Non-IBD controls | VE | FAE | VE | FAE |
Vehicle | 74.1 [62.8–79.9] | 79.2 [65.7–82.3] | 11.9 [9.9–13.5] | 13.7 [11.2–15.3] |
LF82 | 67.1 [58.7–72.0] | 73.3 [61.2–79.7] | 13.7 [9.9–15.8] | 15.2 [11.9–17.1] |
Crohn’s disease | VE | FAE | VE | FAE |
Vehicle | 69.6 [59.5–73.8] | 74.2 [63.5–77.9] | 13.9 [11.5–15.1] | 15.5 [11.2–18.5] |
LF82 | 63.1 [52.3–71.7] | 70.2 [65.7–75.9] | 15.7 [13.4–17.5] | 18.4 [14.0–20.2] |
Segments of villus epithelium [VE] and follicle-associated epithelium [FAE] from nine non-inflammatory bowel disease [IBD] controls and eight patients with Crohn’s disease were mounted in Ussing chambers and exposed to vehicle or E. coli LF82. Comparisons were made with the Mann–Whitney U test. The values above, median [25th–75th percentiles], represent the recordings at 90 min, but there were no significant effects on TER or Isc by E. coli LF82 at any time point.